Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessTexas Instruments Upgraded to "Buy" by Summit Insights Group

Texas Instruments Upgraded to “Buy” by Summit Insights Group

Add to Favorite
Added to Favorite


Summit Insights Group upgraded Texas Instruments (NASDAQ:TXN) to a “Buy” rating, with a current stock price of $193.97.
The company reported Q3 2024 earnings with a revenue of $4.15 billion and a net income of $1.36 billion.
Despite a positive Q3, Texas Instruments projects Q4 revenue to be lower than analyst expectations, between $3.7 billion and $4 billion.

On October 22, 2024, Summit Insights Group upgraded Texas Instruments (NASDAQ:TXN) to a “Buy” rating, with the stock priced at $193.97. Texas Instruments, a leader in the semiconductor industry, specializes in analog and embedded processing products. It competes with companies like Analog Devices and NXP Semiconductors.

During its Q3 2024 earnings call, Texas Instruments reported a revenue of $4.15 billion and a net income of $1.36 billion. The earnings per share were $1.47, slightly above expectations due to a 3-cent benefit from unforeseen items. Despite this, the company projects Q4 revenue between $3.7 billion and $4 billion, below the analyst estimate of $4.07 billion.

The company’s Q4 earnings forecast ranges from $1.07 to $1.29 per share, falling short of the $1.36 per share expected by analysts. This outlook reflects challenges in the analog chip market, with inventory buildup in industrial sectors. However, there are signs of improving demand from China’s automotive market.

Texas Instruments’ stock price has seen a slight decrease of 0.92%, closing at $193.97. The stock fluctuated between $192.85 and $195.30 during the day. Over the past year, it reached a high of $214.66 and a low of $139.48. The company’s market capitalization stands at approximately $177.1 billion.

Summit Insights analyst Kinngai Chan noted that Texas Instruments’ results align with market trends, including mixed performance in PC and smartphone markets. The ongoing weakness in the industrial market, where chips automate factories, continues to impact Texas Instruments and its peers.

Subscribe to get Latest News Updates

Latest News

You may like more
more

LightPath Technologies’ Price Target Raised to $4, Shares Gain 15 percent

LightPath Technologies (NASDAQ:LPTH) shares rose more than 15% intra-day...

MakeMyTrip Target Raised to $130 Amid Steady Growth

BofA Securities analysts increased their price target for MakeMyTrip...

The Bancorp Maintains Momentum with Extended REBL Property Sale Agreement

Piper Sandler analysts reaffirmed their Overweight rating and a...

Masimo’s Target Raised to $194 as Core Healthcare Focus Expected to Drive Growth

Raymond James analysts increased their price target for Masimo...